In an adult male with low total testosterone and low free testosterone, what are the next steps in evaluation and management?

Next Steps After Initial Low Testosterone Results

You must confirm the diagnosis with a repeat fasting morning total testosterone measurement before proceeding further. 1, 2, 3

Immediate Diagnostic Confirmation

• Repeat the morning fasting total testosterone measurement on a separate day to confirm the low value (182 ng/dL is below the typical lower limit of ~300 ng/dL). 1, 2, 3
• The diagnosis of hypogonadism requires both consistent symptoms AND unequivocally low testosterone levels measured on at least 2 separate occasions. 1, 3
• Both measurements should be obtained in the early morning (before 10 AM) in a fasting state, as testosterone levels vary throughout the day. 2, 3

Additional Laboratory Workup

Once you confirm low testosterone with a second measurement, obtain:

• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish between primary hypogonadism (elevated LH/FSH indicating testicular failure) and secondary hypogonadism (low or inappropriately normal LH/FSH indicating hypothalamic-pituitary dysfunction). 1, 2, 3
• Prolactin level to screen for hyperprolactinemia, which can cause secondary hypogonadism. 1, 3
• Consider additional testing based on clinical suspicion: thyroid function tests, iron studies (for hemochromatosis), morning cortisol if Cushing syndrome suspected. 2, 3

Symptom Assessment

Document specific hypogonadal symptoms, as testosterone treatment is only indicated for symptomatic testosterone deficiency:

• Sexual symptoms: decreased libido, erectile dysfunction, reduced ejaculate volume 1, 3
• Physical symptoms: decreased muscle mass and strength, increased body fat, reduced bone density, decreased body/facial hair 1, 3
• Psychological symptoms: decreased energy/vitality, depressed mood, reduced sense of well-being 1, 3

The presence of at least 3 sexual symptoms combined with low testosterone (<320 ng/dL) defines syndromic hypogonadism. 1

Identify Underlying Causes

Screen for reversible causes and comorbidities that may be contributing to functional hypogonadism:

• Obesity and metabolic syndrome: Weight loss and lifestyle modification should be first-line treatment in overweight/obese men before considering testosterone therapy. 1, 4
• Medications: Review for drugs that suppress testosterone (opioids, glucocorticoids, GnRH agonists/antagonists). 1, 4
• Chronic systemic diseases: Type 2 diabetes, HIV, chronic organ failure, sleep apnea. 1, 4
• Pituitary imaging (MRI): Indicated if secondary hypogonadism is confirmed to exclude pituitary adenoma or other structural lesions. 1, 3

Common Pitfalls to Avoid

• Do not diagnose hypogonadism based on a single testosterone measurement, as levels fluctuate and can be transiently suppressed by acute illness, stress, or poor sleep. 2, 3
• Do not start testosterone therapy without confirming symptoms, as the American College of Physicians recommends against treatment for asymptomatic men or those seeking only improvements in energy, vitality, physical function, or cognition. 1
• Do not overlook functional causes: Many cases of low testosterone in middle-aged and older men are secondary to obesity, diabetes, or medications—addressing these underlying conditions may restore testosterone levels without hormone replacement. 1, 4
• Ensure accurate testosterone assay: Use a reliable laboratory method (liquid chromatography-mass spectrometry is preferred over immunoassays for accuracy). 2, 3

When Free Testosterone Measurement Adds Value

Your patient's free testosterone of 0.6 ng/dL (assuming units are ng/dL, which would be ~6 pg/mL) is also low. Free testosterone measurement is particularly useful when:

• Total testosterone is near the lower limit of normal (250-350 ng/dL range). 3
• Conditions affecting sex hormone-binding globulin (SHBG) are present: obesity (lowers SHBG), aging, hyperthyroidism, or liver disease. 2, 3
• Use equilibrium dialysis or calculate free testosterone using validated formulas rather than direct immunoassays, which are unreliable. 2, 3

Treatment Considerations (After Confirmation)

If repeat testing confirms hypogonadism and the patient is symptomatic:

• Discuss testosterone replacement therapy (TRT) for men with sexual dysfunction who desire improvement in sexual function, after reviewing potential benefits, harms, costs, and patient preferences. 1
• Screen for contraindications before initiating TRT: prostate or breast cancer, PSA >4 ng/mL (or >3 ng/mL in high-risk men), hematocrit >50%, severe untreated sleep apnea, severe lower urinary tract symptoms (IPSS >19), uncontrolled heart failure, recent MI/stroke (<6 months). 3, 4
• Intramuscular formulations are preferred over transdermal due to lower cost with similar efficacy and safety profile. 1
• Re-evaluate at 12 months: Discontinue TRT if no improvement in symptoms. 1